Specify a stock or a cryptocurrency in the search bar to get a summary
Adial Pharmaceuticals Inc
ADILAdial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Address: 1180 Seminole Trail, Charlottesville, VA, United States, 22901
Analytics
WallStreet Target Price
17 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ADIL
Dividend Analytics ADIL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ADIL
Stock Valuation ADIL
Financials ADIL
Results | 2019 | Dynamics |